We are pleased to announce that our Operational Director at KD Phyto, Alisia Ratliff, has been invited as a speaker at the annual Cannabis Business Europe Conference 2024 that will be held on June 4th and 5th at the Steigenberger Hotel Bad Homburg in Frankfurt, Germany. and will attend a Q&A session in the Science & Research table.

KD Phyto^® provides affordable, safe, and high-quality access to plant-based pharmaceutical ingredients. KD Phyto^® manufactures active pharmaceutical ingredients (API) from medicinal cannabis or industrial hemp compliant to European pharmacopeia standards and in accordance with best practices set forth by the World Health Organization (WHO) and Good Manufacturing Practices (EU-GMP). In addition to offering CBD and THC bulk API, we are licensed to distribute medicinal cannabis flower and minor cannabinoid isolates (CBG, CBC and CBN).